Neurocrine Bioscience buy Citigroup Inc.
Start price
07.04.26
/
50%
€112.90
Target price
07.04.27
€209.89
Performance (%)
31.75%
Price
08:10
€148.75
Summary
This prediction is currently active. With a performance of 31.75% the BUY prediction by Citigroup_Inc_ is a big success. This prediction currently runs until 07.04.27. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Neurocrine Bioscience | 0.752% | 0.752% |
| iShares Core DAX® | 1.498% | -0.265% |
| iShares Nasdaq 100 | 1.854% | -0.066% |
| iShares Nikkei 225® | 0.411% | 4.084% |
| iShares S&P 500 | 1.479% | 0.783% |
Comments by Citigroup_Inc_ for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences (NBIX) had its price target raised by Citigroup Inc. from $204.00 to $242.00. They now have a "buy" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€123.15
06.05.26
06.05.26
€209.89
06.05.27
06.05.27
20.79%
08:10
08:10
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€103.35
12.02.26
12.02.26
€171.73
12.02.27
12.02.27
43.93%
08:10
08:10
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€117.75
29.10.25
29.10.25
€174.28
29.10.26
29.10.26
26.33%
08:10
08:10